MedTrace Logo

Assessment of the Symbiotic Fermented Milk in Patients With Irritable Bowel Syndrome

NCT02391220 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2015-07-28

No results posted yet for this study

Summary

This study evaluates the effect of a symbiotic fermented milk on health-related quality of life and irritable bowel syndrome (IBS) symptoms in patients with constipation-predominant IBS.

Conditions

  • Irritable Bowel Syndrome

Interventions

OTHER

LCA symbiotic fermented milk

LCA symbiotic fermented milk with the probiotic cultures Lactobacillus acidophilus La-5® and Bifidobacterium animalis ssp. lactis BB-12® and the Beneo dietary fibers.

OTHER

heat-treated fermented milk

heat-treated fermented milk without probiotic cultures and dietary fibres

Sponsors & Collaborators

  • Competence Centre for Biotechnology Research and Innovation

    collaborator UNKNOWN

  • European Regional Development Fund

    collaborator OTHER

  • Ministry of Education, Science and Sport of the Republic of Slovenia

    collaborator UNKNOWN

  • Institute of Dairy Science and probiotics, Biotechnical Faculty, UL

    collaborator UNKNOWN

  • Dairy Celeia

    collaborator INDUSTRY

  • Clinres Farmacija d.o.o.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2013-01-31
Completion
2013-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02391220 on ClinicalTrials.gov